A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based ...
Phase 1 data showed CRISPR’s one-time treatment, CTX310, produced sharp, dose-dependent reductions in triglycerides and LDL ...
Part 1 of the TED Radio Hour episode "The biotech visionaries" Biochemist Jennifer Doudna helped discover the genetic editing tool CRISPR in 2011. Today, as it begins to deliver on its medical ...
Study identifies a new set of genes and cellular pathway that play a role in the risk of developing Parkinson’s disease Scientists searched the entire human genome using CRISPR interference technology ...
In a 15-patient, Phase 1 one, first-in-human trial, a one-time, CRISPR-Cas9 gene-editing therapy safely reduced LDL ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The victory gives UC another ...
PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today. Reading time 3 minutes Who’s up for some CRISPR-y bacon? This week, the Food ...
A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...